ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CrowdStrike Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CRWD
NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ:
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT
NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARDX
NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all
Underage Gamblers Beware: Regulated Online Casinos to Forfeit Winnings and Adopt Biometric Age Verification Tools
WATERFORD, Ireland, Aug. 22, 2024 (GLOBE NEWSWIRE) — In a bid to double down on underage gambling, regulated online casinos globally will forfeit the winnings of those found to be
Bitget Adds Support for PayPal (PYUSD) Stablecoin on Solana Blockchain
Bitget Adds Support for PayPal (PYUSD) Stablecoin on Solana Blockchain VICTORIA, Seychelles, Aug. 22, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has added trading support
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare
Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection BSPG Laboratories SANDWICH, United Kingdom,